Welcome to CDC stacks | Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis - 48994 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
  • Published Date:
    Oct 17 2017
  • Source:
    Emerg Infect Dis. 23(10):1718-1721.
Filetype[PDF-997.61 KB]


Details:
No Related Documents.
You May Also Like:
  1. Coming Soon
    A new era for treatment of drug-resistant tuberculosis
    Personal Author:
    Gandhi, Neel R.; Brust, James C.M.; Shah, N. Sarita;
    Published:
    October 04 2018
    Source:
    Eur Respir J. 52(4)
    Public Access
    Available on:
    October 04, 2019
  2. Six-Month Response to Delamanid Treatment in MDR TB Patients
    Personal Author:
    Hewison, Cathy; Ferlazzo, Gabriella; Avaliani, Zaza; Hayrapetyan, Armen; Jonckheere, Sylvie; Khaidarkhanova, Zarema; Mohr, Erika; Sinha, Animesh; Skrahina, Alena; Vambe, Debrah; Vasilyeva, Irina; Lachenal, Nathalie; Varaine, Francis;
    Published:
    Oct 17 2017
    Source:
    Emerg Infect Dis. 23(10):1746-1748.
    Description:
    Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing tre...
    File Type:
    Filetype[PDF - 336.63 KB]
  3. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
    Personal Author:
    Osman, Muhammad; Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Schaaf, H. Simon; Moore, Brittany K.; Hicks, Robert M.; Achar, Jay; Amanullah, Farhana; Barry, Pennan; Becerra, Mercedes; Chiotan, Domnica I.; Drobac, Peter C.; Flood, Jennifer; Furin, Jennifer; Gegia, Medea; Isaakidis, Petros; Mariandyshev, Andrei; Ozere, Iveta; Shah, N. Sarita; Skrahina, Alena; Yablokova, Elena; Seddon, James A.; Hesseling, Anneke C.;
    Corporate Author:
    for The Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB
    Published:
    Mar 2019
    Source:
    Emerg Infect Dis. 25(3):441-450
    Description:
    Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriol...
    File Type:
    Filetype[PDF - 961.79 KB]
  4. Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
    Personal Author:
    Lardizabal, Alfred A.; Khan, Anum N.; Bamrah Morris, Sapna; Goswami, Neela D.;
    Published:
    Sep 07 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(35):996-997.
    File Type:
    Filetype[PDF - 131.78 KB]
  5. Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
    Personal Author:
    Mbuagbaw, Lawrence; Guglielmetti, Lorenzo; Hewison, Catherine; Bakare, Nyasha; Bastard, Mathieu; Caumes, Eric; Fréchet-Jachym, Mathilde; Robert, Jérôme; Veziris, Nicolas; Khachatryan, Naira; Kotrikadze, Tinatin; Hayrapetyan, Armen; Avaliani, Zaza; Schünemann, Holger J.; Lienhardt, Christian;
    Published:
    May 2019
    Source:
    Emerg Infect Dis. 25(5):936-943
    Description:
    Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia, ...
    File Type:
    Filetype[PDF - 1.25 MB]